ArticleFrontiers in endocrinology2022

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.

Dorota Whitmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.